Walleye Trading’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,694
Closed -$18.2K 5133
2022
Q4
$18.2K Hold
2,694
﹤0.01% 4384
2022
Q3
$21K Hold
2,694
﹤0.01% 4419
2022
Q2
$37K Hold
2,694
﹤0.01% 4412
2022
Q1
$63K Sell
2,694
-841
-24% -$17.6K ﹤0.01% 4437
2021
Q4
$60K Buy
+3,535
New +$65.6K ﹤0.01% 4607

Other funds holding LPCN

Walleye Trading's LPCN Position: Q4 2022 in Review

Walleye Trading sold out of Lipocine (LPCN) in Q4 2022, closing a stake of 6 shares — an estimated $44 sold.

Walleye Trading first reported a position in LPCN in Q2 2015 and held it in 5 quarters. The position peaked at $12K in Q2 2015. 49 funds tracked by Wall St. Rank hold LPCN as of Q4 2022.

  • Walleye Trading reported no remaining Lipocine position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 6 Lipocine shares in Q4 2022, an estimated $44.
  • Walleye Trading first reported a position in Lipocine in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Lipocine position peaked at $12K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Lipocine as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.